Juul in FDA's Sights as U.S. Rethinks Position on E-Cigarettes
- Company’s sales skyrocketed more than 600% in 2017, CDC says
- Findings come as youth vaping jumps, FDA mulls banning flavors
This article is for subscribers only.
U.S. public health officials are changing their stance on the upstart e-cigarette industry.
Last year, the Food and Drug Administration pushed back until 2022 a deadline for e-cigarette companies to submit their products for review in order to continue selling them. Commissioner Scott Gottlieb said he wanted to ease the regulatory pathway for products that are potentially less harmful sources of nicotine than smoking.